ArticleCancer control : journal of the Moffitt Cancer Center

Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.

Sun Hong Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.